PDGF Promotes Dermal Fibroblast Activation via a Novel Mechanism Mediated by Signaling Through MCHR1
Systemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy and excessive fibrosis of the skin and internal organs. To this day, no effective treatments to prevent the progression of fibrosis exist, and SSc patients have disabilities and reduced life expectancy. The need to bette...
Guardado en:
Autores principales: | Naoko Takamura, Ludivine Renaud, Willian Abraham da Silveira, Carol Feghali-Bostwick |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c60a2da41f0a443583523305d072b611 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Scleroderma-like Impairment in the Network of Telocytes/CD34<sup>+</sup> Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis
por: Irene Rosa, et al.
Publicado: (2021) -
Progesterone Aggravates Lung Fibrosis in a Mouse Model of Systemic Sclerosis
por: Fatemeh Vafashoar, et al.
Publicado: (2021) -
RhPDGF – Basic Characteristics and Potential Application in the Oral Surgery – An Overview
por: Mihaylova Z., et al.
Publicado: (2020) -
Methacholine and PDGF activate store-operated calcium entry in neuronal precursor cells via distinct calcium entry channels
por: CUDDON,PAUL, et al.
Publicado: (2008) -
Flu and Pneumococcal Vaccine Coverage in Scleroderma Patients Still Need to Be Prompted: A Systematic Review
por: Francesca Rosamilia, et al.
Publicado: (2021)